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a b s t r a c t
DNA damage tolerance pathways facilitate the bypass of DNA lesions encountered during replication.
These pathways can be mechanistically divided into recombinational damage avoidance and translesion
synthesis, in which the lesion is directly bypassed by specialised DNA polymerases. We have recently
shown distinct genetic dependencies for lesion bypass at and behind the replication fork in the avian
cell line DT40, bypass at the fork requiring REV1 and bypass at post-replicative gaps requiring PCNAeywords:
NA damage tolerance
ranslesion synthesis
erner’s Syndrome
CNA ubiquitination
ubiquitination by RAD18. The WRN helicase/exonuclease, which is mutated in the progeroid and cancer
predisposition disorder Werner’s Syndrome, has previously been implicated in a RAD18-dependent DNA
damage tolerance pathway. However, WRN has also been shown to be required to maintain normal
replication fork progression on a damaged DNA template, a defect reminiscent of REV1-deﬁcient cells.
Here we use the avian cell line DT40 to demonstrate that WRN assists REV1-dependent translesion
n for
ckupRN
EV1
synthesis at the replicatio
provides an important ba
. Introduction
DuringDNAreplication, attempts to excise and repairDNAdam-
ge are likely to result in replication fork collapse. Cells therefore
sually opt to bypass damage encountered by replication forks,
nstead deferring repair until replication has been completed. DNA
amage bypass can take two general forms [for recent reviews
ee [1,2]]. The most direct is translesion synthesis, in which the
talled replicative polymerases are replaced by specialised transle-
ion polymerases whose active sites are able to accommodate
dducted or distorted bases. Alternatively, cells can employ one
f the recombinational modes of bypass that require an undam-
ged template, usually the newly synthesised daughter strand on
he sister chromatid. In principle, lesion bypass can take place
ither at the replication fork or at post-replicative gaps created
hen replication restarts downstream of an arrested fork. We have
ecently demonstrated that, in DT40, these temporally distinct
esion bypass pathways are genetically deﬁned by requirements
or the C terminus of the Y-family DNA polymerase REV1 and the
onoubiquitination of the DNA sliding clamp PCNA respectively
3]. Monoubiquitination of PCNA by the E3 ubiquitin ligase RAD18
4–6] plays a central role in the control of DNA damage tolerance
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el.: +44 1223 252941; fax: +44 1223 412178.
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oi:10.1016/j.dnarep.2010.07.006k and that PCNA ubiquitination-dependent post-replicative lesion bypass
mechanism for damage tolerance in the absence of WRN protein.
© 2010 Elsevier B.V. All rights reserved.
in all eukaryotes studied to date [4–8] both through controlling the
recruitmentof translesionpolymerases andbypromoting recombi-
national bypass. However,whilemore is nowunderstood about the
mechanisms that control lesion bypass pathways, little is known
about the accessory factors that facilitate these processes. A num-
ber of recent lines of evidence, discussed below, suggest that WRN
is potentially one such factor.
Werner’s Syndrome (WS, OMIM 277700) is an autosomal reces-
sive disorder caused by mutations in the WRN gene [9] and
is characterised by a variety of disorders reminiscent of pre-
mature ageing; cataracts, type II diabetes mellitus, osteoporosis,
atherosclerosis as well as a high incidence of unusual cancers.
WRN encodes a member of the RecQ family of helicases [10] but
also contains a ‘helicase, RNaseD, C-terminal conserved’ (HRDC)
domain, which has DNA-binding activity [11,12], and 3′–5′ exonu-
clease activity due to a motif located near the N terminal of the
protein [13].
The defects in WRN-deﬁcient cells, which include slow growth,
spontaneous genetic instability and sensitivity to a range of DNA
damaging agents, arise from the involvement of WRN in a very
wide rangeofDNA transactions includingbase excision repair, non-
homologous end joining and transcription [reviewed in [14]].Much
evidence, however, points to its involvement in processes at or
around the replication fork. Similarly to RecQ in E. coli [15] and
Rqh1 in S. pombe [16], there is evidence that WRN helps to avoid
recombination [17], possibly by promoting damage tolerance, the
set of mechanisms that promote DNA damage bypass during repli-
cation. WRN has also been reported to play a role in homologous
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ecombination itself at the level of the resolution of recombination
ntermediates [18–21].
Evidence implicating WRN in DNA damage tolerance pathways
omes from a number of sources. WRN interacts functionally with
he Y-family translesion polymerases ,  and , stimulating their
xtension activity in the absence of PCNA [22]. WRN alleviates
ausing of these polymerases at lesions by increasing the vmax of
olymerization, hence it was proposed that it may promote the
rogression of replication forks at the expense of increased muta-
enesis. This stimulatory effect of WRN on TLS polymerases was
ound to be present even in WRN mutants lacking either helicase
r exonuclease activities. WRN also co-localises with pol  after
V-C irradiation, but formation of WRN foci did not depend on the
resence of pol [22] and a direct interaction between the proteins
as not been shown.
Genetic studies inDT40 suggest thatWRN functions in a RAD18-
ependent DNA damage tolerance pathway [23] with a wrn/rad18
ouble mutant exhibiting sensitivity to NQO or MMS equal to that
f the rad18 single mutant. From our previous work showing that
AD18 deﬁnes a post-replicative pathway of damage bypass [3],
hese data suggest that WRN too would act behind the replication
ork. However, using DNA ﬁbre labelling, WRN has been shown to
e required for normal replication fork progression on DNA dam-
ged with MMS [24], suggestive of a model in which WRN assists
ypass of lesions at the replication fork. This phenotype is reminis-
ent of REV1-deﬁcient cells in similar ﬁbre labelling assays [3,25]
nd suggests that WRN is required at the replication fork.
To resolve the question of which of the temporally distinct
ypass pathways, deﬁned by RAD18-dependent PCNA ubiquitina-
ion and by REV1 [3], WRN is involved in we generated isogenic
utants in the chicken cell line DT40. Using a newly created wrn
T40 that lacks any detectable transcript, we show thatWRNoper-
tes in a pathway dependent on REV1 to maintain replication fork
rogression following DNA damage and that RAD18-dependent
ost-replicative gap ﬁlling provides an important backup activity
hen WRN is lost.
. Materials and methods
.1. DT40 lines, culture and transfection
Culture and transfection of DT40 was carried out as described
reviously [26]. The rev1 and pcnaK164R cell lines have also been
reviously described [26,27]. The rad18 mutants used were gen-
rated in our laboratory using constructs described by Takeda and
o-workers [28].
.2. WRN locus targeting construct assembly
The WRN targeting construct was assembled in pBluescript
K+ using a custom multiple cloning site (KpnI-NotI-MluI-
paI-EcoRI-BamHI-SacI) made by annealing and ligating the
ligonucleotides cWRNMCSF [5′-CGCGGCCGCACGCGTGGGCCCGAAT-
CGGATCCGAGCT] and cWRNMCSR [5′-CGGATCCGAATTCGGGCCCAC-
CGTGCGGCCGCGGTAC]. The 2.89kb 5′ arm of homology was
mpliﬁed by PCR from DT40 genomic DNA using primer pair
WRKO5F2 [5′-CAGAGAGAATAACGCGTCATAAAGATTGTATCTAAATT-
CTAGTCTTC] andcWRKO5R2 [5′-CTCAGGAAACAGCCACATACAAAAG-
GCCCGTAATAGTTTCCAGTTCC], which introduce MluI and ApaI sites
t the 5′ and 3′ ends respectively. The 5.54kb 3′ arm of homol-
gy was ampliﬁed from genomic DNA using primers cWRKO3F1
5′-GGTGTTTGTTTGCCTGTGGCCGGGCATGG] and cWRKO3R1 [5′-
CCATAAGCTCTGAGCTCTTGGGCCATGTTG] which introduce a BamHI
ite at the 5′ end of the arm. An endogenous SacI site is present at
he 3′ end. The 5′ arm was inserted into the modiﬁed pBluescriptair 9 (2010) 1064–1072 1065
ﬁrst, followed by the 3′ arm and then an antibiotic resistance cas-
sette (either neomycin, puromycin, blasticidin or histidinol) was
introduced into theBamHI site. The neomycin, puromycin andblas-
ticidin resistance markers are removable using Cre recombinase as
they are ﬂanked by modiﬁed LoxP sites [29].
2.3. Conﬁrmation of WRN disruption
After targeting of the ﬁrst and second alleles, disruption was
conﬁrmed by Southern blot probing from the 3′ end (Fig. 1A
and B). Probe DNA for Southern blotting was made by ampli-
ﬁcation of DT40 genomic DNA using the primers cWRKOPF1
[5′-GTTAATACCGTGGCTTGCTGAAGCATTTCTTGAC] and cWRKOPR2
[5′-GCTCAGCTGTAGGCTTTTGTTTTAATGAACACAAC], cloned into pCR
2.1-TOPO then excised as a SpeI, XhoI fragment. Genomic DNA from
transfected clones was digested with BamHI before Southern blot-
ting.
Loss of WRN transcript was also conﬁrmed by qPCR, car-
ried out using a 7900HT Fast Real-Time PCR System (Applied
Biosystems). Reactions were performed in MicroAmp fast
optical 96-well reaction plate (Applied Biosystems) sealed
with MicroAmp Optical Adhesive Film (Applied Biosystems)
using SYBR GreenER qPCR SuperMix Universal (Invitrogen)
and ROX reference dye. All reactions were carried out using
cDNA template with primers at 400M. Primers to amplify
WRN cDNA were designed to hybridize to the exons 19–20
and exons 22–23 junctions (Exon1920F has sequence 5′-
GCGGGATGAAATCCAGTGTGTTGTGG and Exon2322R has sequence
5′-GAGGTTGCCAAACAAGAGGTTCTGCACCTG) Relative amounts of
transcripts were determined using comparative quantitation rel-
ative to wild type, using -actin as the normaliser. Primers used to
amplify -actin were BActinF1 [5′-GAGAGAAGATGACACAGATCATG]
and BActinR1 [5′-GACTCCATACCCAAGAAAGATGG].
2.4. Measurement of growth kinetics
Cells were diluted to a density of 1×104/ml in medium and
incubated (37 ◦C). Viable cells were counted using a Vi-CELL cell
viability analyser (Beckman Coulter) at 24h intervals for 96h.
2.5. Cell cycle analysis
Cell cycle analysis was performed as previously described [30].
Incorporated 5-bromo-2′deoxyuridine was stained using a 1:200
dilution of rat anti-BrdU antibody (BD Biosciences) followed by
a 1:100 dilution of FITC-conjugated goat anti-rat antibody (BD
Biosciences). FACS analysis was carried out using a FACScalibur
ﬂow cytometer (Beckman Coulter) and FlowJo 8.5.2 software (Tree
Star/Stanford University).
2.6. Post-replication repair assay
Post-replication repair assays were carried out as previously
described [3].
2.7. Colony survival assays
Colony survival assays were performed as previously described
[31].2.8. DNA ﬁbre spreading and labelling
DNA ﬁbre spreading and labelling was carried out as described
[3]. 100 doubly labelled ﬁbres were counted for each condition.
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Fig. 1. Generation of a WRN null DT40 line. (A) Schematic of the WRN gene targeting strategy. The binding sites of the primers used to generate the 5′ and 3′ arms of the
targeting construct are shown above the locus map, along with the restriction sites used in their cloning. A selection cassette replaces exon 2 of the WRN transcript and
which, following targeted integration, is predicted to lead to an out of frame splice event between exons 1 and 3 resulting in a stop codon 16 amino acids into exon 3. The
Southern probe spanning exon 5 is indicated. (B) BamHI digested genomic DNA from wild type (WT), WRN+/−and WRN−/−(wrn) cells probed as indicated above. All lanes are
from the same blot, but intervening lanes have been cut out between WT and +/−. (C) qPCR for exons 19–23 conﬁrming loss of WRN transcript downstream of the disruption
in four clones. (D) Growth of wild type (WT) and wrn clone P6. The graph represents three independent experiments with the error bars indicating the standard deviation.
(E) Comparison of the doubling time in four independent clones of wrn DT40. (F) Cell cycle distribution of cells in asynchronous cultures of wild type and wrn lines. The mean
percentage of 3 independent determinations is shown and the error bars represent one standard deviation.
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Fig. 2. WRN and PCNA ubiquitination act in separate pathways. (A) Epistasis analysis of WRN and RAD18 for survival following treatment with 254nm UV light (UV) and
cisplatin (CDDP). (B) Epistasis analysis of WRN and cells carrying a point mutation of PCNA at K164, which prevents ubiquitination, for survival following treatment with
254nm UV light (UV) and cisplatin (CDDP). Error bars represent the one standard deviation from the mean of three independent experiments. For clarity only the positive
error bar is shown. C. Sister chromatid exchange in wrn and rad18 cells. SCE with (black bars) and without (light grey bars) treatment with 0.2ng/ml NQO. The histogram
i -axis
m cases,
t ad18 a
T
l
3
3
Dndicates the percentage of metaphases with the number of SCE indicated on the X
etaphases, is indicated above the histogram. For both untreated and NQO-treated
-test, p<0.0001). There is no signiﬁcant difference between wild type and wrn or r
hese were derived from c. 8 slides made from two independent
abelling experiments.
. Results and discussion.1. Generation of a completely null wrn DT40 line
For this study we wished to produce a completely null wrn
T40 cell line, since an earlier wrn DT40 mutant retains a. The mean number of SCE in each case, derived from blind scoring of at least 100
the difference between wild type and rad18 SCE is statistically signiﬁcant (unpaired
nd wrn/rad18.
substantial transcript (2.5 of 4.5 kb) as assessed by Northern
blot [32]. To achieve this we replaced exon 2 in both alleles
of the DT40 WRN gene with a selectable marker by homol-
ogous recombination (Fig. 1A and B). Splicing of exon 1 to
exon 3 results in an out of frame transcript and introduces a
stop codon 16 amino acids into exon 3. qPCR corresponding
to exons 19–23 on cDNA from the targeted clones conﬁrmed
the success of this strategy with no transcript detectable
(Fig. 1C).
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mig. 3. WRN is not required for post-replicative gap ﬁlling. Upper panels: Wild type
ith [3H]-thymidine for 20min and either lysed immediately (grey lines) or chased
ham-irradiated cells.
.2. The phenotype of wrn DT40 resembles that of WS patient cells
Our wrn DT40 clones grew slowly, as has been reported for
uman WS ﬁbroblast lines [33]. We initially characterised four
ndependent wrn clones, all of which showed a comparable reduc-
ion in doubling time. For example clone P6 had doubling time at
7 ◦C of 20.2±4.0h compared to 11.0±0.8h for the parental wild
ype, measured concurrently (Fig. 1D and E). Similar to human WS
broblasts [reviewed in [34]], this was largely explained by a pro-
onged cell cycle rather than an increase in spontaneous apoptosis
Fig. 1F). The increase in the proportion of G1/G0 cells in an asyn-
hronous culture of the wrn mutant to 22.7%, from 12.7% in wild
ype, corresponds to wrn cells spending an average of 4.5h in G1 as
pposed to 1.4h for wild type (Fig. 1F). Further, S-phase was also
rolonged from 6.4h in wild type to 11.3h in wrn cells, again in
greement with studies of human WS cells [33,35,36]. Similar to
uman WS ﬁbroblasts [37–42], wrn DT40 were modestly sensitive
o a number of agents expected to create replication blocks includ-
ng ultraviolet light [D10 8.3 vs. 4.8 J/m2, for wild type (Fig. 2A)], the
dduct/cross-linking agent cisplatin (CDDP) [D10 34.1 vs. 45.7M
Fig. 2A)], methylmethane sulphonate (MMS) [D10 99.8 vs. 142.1
arts per million (data not shown)] and nitroquinoline-1-oxide
NQO) [D10 23.7 vs. 41.5nM (data not shown)].
.3. Complete WRN disruption is not epistatic with defective
CNA ubiquitination
Previous work has suggested that WRN functions in a RAD18-
ependent damage avoidance pathway [23]. We re-examined this
elationshipbydisrupting theWRN loci usingour construct in rad18
28] and pcnaK164R [27] DT40 lines. Epistasis analysis for sensi-
ivity to 254nm UV light and cisplatin (CDDP) showed that both
rn/rad18 and wrn/pcnaK164R double mutants were markedly
ore sensitive than either of their respective single mutants8, wrn and rad18/wrn cells were irradiated with 4 Jm−2 254nm light, pulse labelled
0’ in medium containing 10M thymidine before lysis (black lines). Lower panels:
(Fig. 2A and B), showing that WRN acts largely independently of
PCNA ubiquitination and, indeed, suggests that PCNA ubiquitina-
tion plays an important role inmaintaining the viability ofwrn cells
following genotoxic stress.
A striking feature of rad18 mutant lines is elevated spontaneous
sister chromatid exchange [28,43]. This arises from a combina-
tion of channelling DNA lesions away from RAD18-dependent DNA
damage tolerance pathways to classical homologous recombina-
tion and from a role played by RAD18 in recombination itself [44]
that is independent of PCNA ubiquitination [6]. In contrast, it has
been reported that inactivation of WRN in human cells does not
result in elevated SCE [45]. As previously observed, rad18DT40 cells
exhibit elevated levels of SCE in the absence of any exogenously
appliedDNAdamage,with amean of 7 permetaphase (Fig. 2C). The
level of SCE rose further following treatment with NQO to 10 per
metaphase (Fig. 2C). However, in agreementwith studies in human
WS cells [45], wrn DT40 do not exhibit elevated spontaneous SCE
or an exaggerated SCE response following exposure to NQO and
the wrn/rad18 double mutant behaves the same as the rad18 single
mutant within the sensitivity limit of this assay (Fig. 2B).
3.4. WRN is not required for post-replicative gap ﬁlling
In DT40, RAD18-mediated PCNA ubiquitination controls DNA
damage bypass at post-replicative gaps that are formed in conse-
quence of replication fork arrest with downstream resumption of
replication [3]. Thus,whenPCNAubiquitination isdefective the rate
at which single stranded gaps are ﬁlled is reduced, i.e. PCNA ubiq-
uitination mutants exhibit defective post-replication repair. A key
prediction of the notion thatWRN functions in a RAD18-dependent
damage avoidance pathway [23] is that WRN should also operate
behind the fork. This can be monitored by following the incorpo-
ration of a tract of tritiated label into high molecular weight single
strandedDNAbyvelocity sedimentationonanalkaline sucrose gra-
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Fig. 4. WRN is required to maintain replication fork progression on a damaged DNA template. (A) Schematic of DNA labelling experiments. Cells are pulse labelled ﬁrst with
chlorodeoxyuridine (CldU) for 20min and then with iododeoxyuridine (IdU) for 20min. DNA damage can be added along with the IdU to assess the effect on replication
progression compared with the ﬁrst labelling period without damage. Each period of labelling corresponds to synthesis of about 20kb of DNA. Note the concentrations of
drug used are supralethal in order to achieve a high probability of damage forming within c. 20kb ahead of the fork [3]. (B) Fork progression on undamaged DNA in wrn
cells is comparable to wild type (WT). Average fork rate during the ﬁrst 20min calculated using a previous calibration for this method [51] from 100 doubly labelled ﬁbres
f differ
r e-1-o
o e-1-o
s d the p
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aor each case. The error bars indicate one standard deviation. There is no signiﬁcant
atios showing replication stalling in response to increasing doses of 4-nitroquinolin
f DNA ﬁbre CldU:IdU ratios. WT: dashed lines; wrn: solid lines. (D) 4-nitroquinolin
igniﬁcance was assessed using the two-sample Kolmogorov–Smirnov (K–S) test an
ient [46]. We observed, as previously reported [3,47] that rad18
ells exhibit delayedgapﬁlling (Fig. 3).However, suchadefect isnot
een in wrn cells and the defect in the wrn/rad18 line is compara-
le to that seen in the rad18 single mutant (Fig. 3). This suggests
hat WRN is not essential for timely post-replicative gap ﬁlling
nd together these data do not support WRN acting in the PCNA
biquitination-dependent post-replicative DNA damage tolerance
athway.
Our conclusions are, on the face of it, inmarked contrast to those
eached by Dong et al. [23]. We believe that the discrepancy likely
rises from the incomplete inactivation ofWRN in theDT40mutantence between WT and wrn (unpaired t-test). (C) Histograms of DNA ﬁbre CldU:IdU
xide (NQO). Wild type: grey bars; wrn: red bars. (D–F) Cumulative percentage plots
xide (NQO). (E) Methylmethane sulphonate (MMS). (F) Cisplatin (CDDP). Statistical
robability that there is no difference between WT andwrn at each dose is indicated.
used in the earlier study [32]. Although the targeting approached
used in the work of Dong et al. will inactivate the helicase domain,
most cases of WS are a result of complete functional inactivation
of the gene. Loss of just the helicase activity of WRN results has
been previously shown to result in a distinct and milder pheno-
type comparedwith complete inactivationof theprotein [21]. Thus,
while we cannot exclude that the helicase activity of WRN partic-
ipates in PCNA ubiquitination-dependent damage avoidance, our
results clearly demonstrate that the complete WRN protein ful-
ﬁls an important function in the absence of PCNA ubiquitination.
To further address this issue, we have tried extensively to per-
1070 L.G. Phillips, J.E. Sale / DNA Repair 9 (2010) 1064–1072
Fig. 5. WRN acts in a REV1-dependent pathway to promote replication fork progression on damaged DNA. (A) Fork progression on undamaged DNA in wild type (WT),
wrn, rev1 and wrn/rev1 cells. There is no signiﬁcant difference between any of the lines (unpaired t-test). (B) Cumulative percentage plots of DNA ﬁbre CldU:IdU ratios
with 10g/ml NQO added during the second (IdU) labelling period for wild type (black line), wrn (red line), rev1 (blue line) and wrn/rev1 green line. Statistical signiﬁcance
assessed by the two-sample K-S test is indicated. (C and D) Epistasis analysis of WRN and REV1 (C) and REV3 (D) for survival following treatment with 254nm UV light. E.
Summary of the replicating plasmid assay for lesion bypass. For full details see Szüts et al. [50]. Brieﬂy, the plasmid pQTS, which can support replication in DT40, contains
staggered T–T (6-4) photoproducts placed opposite a GpC mismatch, since this is an uncommon insertion opposite this lesion. This arrangement allows determination of TLS
and recombinational bypass by template switching. Since GpC opposite the lesion would also arise as a result of nucleotide excision repair, the assay is carried out in an xpa
background. (F) The proportion of TLS vs. error-free bypass in pQTs sequences recovered from xpa (n=130) and xpa/wrn cells (n=70), shown as percentage of the total. (G)
The pattern of nucleotide incorporation opposite the T–T (6-4) photoproduct. The percentage of each nucleotide incorporated at each position is indicated by the size of the
letter of the nucleotide in the column; del: deletion.
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orm complementation of ourwrnmutant. However, we have been
nable to obtain clones ectopically expressing the WRN protein
espite using a number of different promoter systems. Itwill there-
ore be necessary to further these studies by creating endogenous
utations in the WRN locus.
.5. WRN is required to maintain replication fork progression on
amaged DNA
Recent data from WRN-depleted human cells have implicated
RN in maintaining replication fork progression on a damaged
NA template [24]. Fork progression ismonitored by labelling DNA
n vivo with halogenated nucleotides and then spreading the DNA
bres on a glass slide. The tracts of labelled DNA are revealed by
enaturation and staining with antibodies that recognise halo-
enated bases. In our version of this assay [3], we sequentially
abelled cells with chlorodeoxyuridine (CldU) and iododeoxyuri-
ine (IdU). During the second labellingperiodwedamaged theDNA
uch that the advancing fork will encounter DNA damage and may
tall (Fig. 4A). We can then monitor, in a large number of ﬁbres, the
ength of tract replicated before and after the application of DNA
amage.
In the absence of DNA damage the replication rate of wrn cells
as comparable to wild type at around 1kb/min (Fig. 4B). To assess
he effect of disruption of WRN on fork progression following DNA
amage we performed titrations in which increasing doses of DNA
amaging agent were added during the second labelling period.
amage arresting replication during the second labelling period
ill result in shortening of the IdU labelled tract and an increase
n the ratio of CldU:IdU tract lengths. As the position of the stall
s random, this ratio increases stochastically resulting in both an
ncrease in the mean CldU:IdU ratio and in the spread of values
Fig. 4C). A convenient method to represent this data is as a cumu-
ative percentage of forks at each ratio (Fig. 4D–F). For all doses
f NQO, methyl methane sulphonate and cisplatin wrn cells (solid
ines) exhibited a more profound inability to maintain replication
ork progression on a damaged template compared with wild type
dashed lines), in agreement with the recent work on human cells
24].
.6. WRN functions at the replication fork to facilitate
EV1-dependent translesion synthesis
This phenotype is strongly reminiscent of cells lacking REV1
3,25]. REV1 plays a crucial role in coordinating translesion synthe-
is at the replication fork by coordinating, through its C terminus,
nteractions between PCNA and translesion polymerases [3,48,49].
e therefore wished to know whether this phenotypic similarity
etween WRN and REV1 was a reﬂection of their operating in com-
on damage bypass pathway at the replication fork. To do this we
reated a wrn/rev1 double mutant. In the absence of damage these
ells show no defect in DNA replication rate on undamaged DNA
Fig. 5A). To examine the effect of DNA damage we chose a dose
f NQO (10g/ml) at which we would expect to be able to read-
ly detect an additive effect of the double disruption (see Fig. 4D).
n a side-by-side comparison, rev1 cells exhibited a more profound
efect in fork progression followingdamage thanwrn cells (Fig. 4B),
ut importantly the double wrn/rev1 mutant was no worse than
ev1on its own. This suggests thatWRNoperates at a subsetof repli-
ation impediments at the fork that require REV1 for their bypass
r resolution.We next examined the genetic relationship between WRN and
EV1 and REV3 for sensitivity to UV light. These experiments
evealed a clear epistatic relationship between WRN and REV1/3-
ependent translesion synthesis, the double mutants exhibiting no
dditional sensitivity to the single TLS mutants (Fig. 5C and D). This
[
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is in marked contrast to the relationship between WRN and PCNA
ubiquitination (Fig. 2B). Together, these data suggest that WRN
and REV1 can operate in a common pathway for the alleviation
of replication arrest.
We have previously shown that REV3 is essential for translesion
synthesis across (6-4) T–Tphotoproducts, amajorUV-inducedDNA
lesion, in vivo in a replicating plasmid assay that can monitor the
relative use of TLS and recombinational bypass (Fig. 5E) [50]. We
also showed that loss of REV1 not only diminished the frequency of
use of TLS but also resulted in reduced TLS frame ﬁdelity. To exam-
ine the impact of the wrn mutation in this assay, we inactivated
nucleotide excision repair, as previously described, by disrupting
the XPA locus [50]. Since the lesion is placed opposite a G–C mis-
match, this allows the distinction of recombinational bypass from
excision repair. Interestingly, wrn/xpa cells exhibited a very similar
frequency of TLS usage (Fig. 5E) and no alteration in the muta-
tion spectrum created by the use of TLS compared with xpa cells
(Fig. 5F). This suggests that WRN does not directly inﬂuence the
TLS reaction itself or impact mutagenesis, at least in this context.
Rather it appears to be required for efﬁcient use of TLS at a subset of
events at the fork. It will ultimately be interesting to determine the
circumstances under which WRN is required. Nonetheless, in the
absence ofWRN,we suggest that bypass ismore likely to take place
behind the fork explaining the marked reliance of wrn mutant cells
on PCNA ubiquitination.
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